Skip to main content
Pre-Symposium Nursing Seminar (Nov. 2)
Join your colleagues for a day of networking and exploring issues in pediatric oncology from a nursing perspective. All disciplines welcome!
Symposium - Day 1 (Nov. 3)
Examining clinical and scientific advances in the field of pediatric oncology: 40 years of progress
Symposium - Day 2 (Nov. 4)
Examining clinical and scientific advances in the field of pediatric oncology: 40 years of progress
8:00 AM — 8:50 AM
Registration & Continental Breakfast
8:50 AM — 9:00 AM
Opening Remarks
9:00 AM — 9:50 AM
Patient-Centered Care in Pediatric Oncology: Exploring Patient-Reported Outcomes from the Past to the Present

This presentation will define patient-reported outcomes (PROs), discuss how PROs have been used in research, and identify opportunities to translate PROs into the clinical setting.

Kitty Montgomery picture
Kitty Montgomery
9:50 AM — 10:30 AM
Bioethics at the Bedside

This presentation will review ethical issues that are encountered in daily practice, implications and the implementation of an Ethics Liasion Program. 

Kim Pyke-Grimm picture
Kim Pyke-Grimm
10:30 AM — 10:50 AM
Morning Break
10:50 AM — 11:15 AM
QUICK HIT: Blinatumomab - the Bs, Burden, Bags, and Backpacks

This presentation will provide an update on administering Blinatumomab to pediatric patients, including challenges, and updates to practice as a result of lessons learned over the past decade.

Sue Zupanec picture
Sue Zupanec
11:15 AM — 11:40 AM
QUICK HIT: Late Effects in Neuroblastoma

This presentation will review the historical late effects seen with conventional therapy for High-Risk Neuroblastoma. It will also explore some of the new data that has come out of the most recent COG "LEAHRN" (Late Effects after High-Risk Neuroblastoma) study. The aim of this study was to examine late effects after modern neuroblastoma treatment with immunotherapy.

Eleanor Hendershot picture
Eleanor Hendershot
11:40 AM — 12:05 PM
QUICK HIT: Skin Care for Patients Receiving MEK Inhibitors: What You Need to Know

This presentation will: (1) identify common skin manifestations and rare side effects when administering MEK inhibitors; (2) Provide anticipatory guidance, prophylaxis skin care for patients and families; (3) Share case studies to understand various medical management for common or chronic skin manifestations.

Tara McKeown picture
Tara McKeown
12:05 PM — 12:25 PM
QUICK HITS Q&A
12:25 PM — 1:25 PM
Lunch
1:25 PM — 2:20 PM
A bit of a sore mouth? Preventing and managing mucositis
Bob Phillips picture
Bob Phillips
2:20 PM — 3:00 PM
Parental Distress and Trauma in Parents of Children Diagnosed with Acute Lymphoblastic Leukemia

This presentation will focus on recent research into the distress experience of the parents of children with acute leukemia, conducted at the Hospital for Sick Children and the Princess Margaret Cancer Centre. Specifically, this presentation will review results from a prospective longitudinal study of parental traumatic stress and related health outcomes, as well as results from a pilot trial of a psychotherapeutic intervention to manage this distress.

Lindsay Jibb picture
Lindsay Jibb
3:00 PM — 3:25 PM
Afternoon Break
3:25 PM — 4:05 PM
More Than The Birds & The Bees: Fulfilling an unmet need in adolescent cancer care

At least half of young adult survivors of childhood cancer struggle with at least one major sexual problem within two years of diagnosis. As essential providers in the care of these patients and their loved ones, nurses can lo longer wait for "someone else" to address these issues. Nurses are well positioned to discuss sensitive topics such as sexuality concerns with patients because of their compassion, knowledge, established trust and access to AYA cancer patients. This session will provide participants with strategies to initiate these uncomfortable conversations and identify available resources for patients and providers. 

Stacy Whiteside picture
Stacy Whiteside
4:05 PM — 4:50 PM
Caring for Children with Cancer and Autism

Children and youth with autism spectrum disorder (ASD)​ may face unique challenges coping with the diagnosis and treatment of cancer, healthcare encounters and procedures, and hospitalization. This session will discuss how to adapt care and develop individualized strategies to support children and youth with ASD and cancer throughout their journey.

 

Joelene Huber picture
Joelene Huber
Chantal St. Jules picture
Chantal St. Jules
4:50 PM — 4:55 PM
Survivor Perspectives: Lindsay's Story
4:55 PM — 5:00 PM
Closing Remarks
7:30 AM — 8:15 AM
Registration and Breakfast/Posters on Display
8:15 AM — 8:25 AM
Opening Remarks
8:25 AM — 8:30 AM
Survivor Perspectives: Kirsten's Story
8:30 AM — 9:20 AM
40 Years of Progress: POGO Through a Retrospectoscope
Mark L. Greenberg picture
Mark L. Greenberg
9:20 AM — 10:10 AM
It's the difference between existing and living: 40 years of research in supportive care

How has supportive care changed over 40 years? Does it really make a difference or is it just glitter and sparkles? When is a great idea not a good thing? What haven't you asked that you want to? These questions, to some extent, will have answers offered. 

Bob Phillips picture
Bob Phillips
10:10 AM — 10:35 AM
Supportive Care in Action: An Update on POGO’s Infection Care Pathway Project

One of the strategic objectives of the Childhood Cancer Care Plan: A Roadmap for Ontario 2018- 2023 is to promote enhanced supportive care through clinical practice guideline (CPG) development and uptake. We will describe the development and implementation of institution specific supportive care pathways for infection prevention and management in the POGO network. We will also describe efforts to harmonize the care provided to children with cancer across Ontario in terms of supportive care for infection prevention and management.

Adam Yan picture
Adam Yan
10:35 AM — 10:40 AM
Survivor Perspectives: Eugene's Story
10:40 AM — 11:10 AM
Morning Break

SPECIAL INTEREST SESSIONS

Special interest sessions take place concurrently. There are four to choose from and they are offered on both Friday and Saturday. These sessons are designed to be interactive and conducive to discussion and collective problem-solving. 

11:10 AM — 12:10 PM
Special Interest Session A: Interesting Cases in Pediatric Lymphoma

Using patient-based scenarios, this session will focus on the complexities and emerging opportunities in the management of Hodgkin lymphoma in childhood, adolescents, and young adults. In addition, participants are invited to engage in a discussion of the role of patient reported outcomes, shared decision making and drug access in treatment decisions.

Angela Punnett picture
Angela Punnett
Jennifer Seelisch picture
Jennifer Seelisch
11:10 AM — 12:10 PM
Special Interest Session B: Decision-making in Adolescents and Young Adults with Cancer
Abha Gupta picture
Abha Gupta
Kim Pyke-Grimm picture
Kim Pyke-Grimm
11:10 AM — 12:10 PM
Special Interest Session C: Diagnostic and Treatment Advances in Pediatric Solid Tumours

Despite survival improvements owed to traditional cytotoxic chemotherapy in pediatric solid tumors in the past 4 decades, patients with relapsed or refractory disease continue to have poor outcomes. There is a clear need therefore for novel therapeutics and targeted agents in this difficult to treat patient population. This session will use a series of solid tumor cases to explore the considerations in using novel therapeutics both within and outside of clinical trial settings.

Paul Gibson picture
Paul Gibson
Marija Kacar picture
Marija Kacar
11:10 AM — 12:10 PM
Special Interest Session D: Overcoming Barriers to Make Fertility Preservation Standard of Care in Ontario
Jennia Michaeli picture
Jennia Michaeli
Stacy Whiteside picture
Stacy Whiteside
12:10 PM — 1:05 PM
Lunch
1:05 PM — 2:00 PM
The Evolution of Blinatumomab in Acute Lymphoblastic Leukemia

This presentation will discuss the history of blinatumomab in both adult and pediatric acute lymphoblastic leukemia, and what the future may or may not hold for the role of this agent.

Sumit Gupta picture
Sumit Gupta
2:00 PM — 2:40 PM
The Psychosocial Landscape of Pediatric Oncology

This presentation will provide an overview of the current evidence related to the mental health of pediatric cancer patients, emphasizing the increased burden of mental health difficulties post-COVID. It will also include exciting new initiatives to support the mental health needs of pediatric cancer patients.

Fiona Schulte picture
Fiona Schulte
2:40 PM — 3:10 PM
Ontario Health’s Mental Health Strategy: Current Resources and Future Plans to Help Young Patients Access the Mental Health Care They Need

This presentation will describe the current and future state of Youth Wellness Hubs Ontario as a system-wide initiative to support the health and wellbeing of youth aged 12-25 years. Available mental health, substance use, health, and other community and social support across the province will be outlined. Future plans to enhance services and outcomes through operating as a learning health system will also be described.

Maria Talotta picture
Maria Talotta
3:10 PM — 3:25 PM
Combined Q&A
3:25 PM — 3:55 PM
Afternoon Break
3:55 PM — 4:10 PM
Rapid Fire Research: 3-minute poster presentations

 

A Cost-Utility Analysis of Nelarabine for the First-Line Treatment of T-Cell Acute Lymphoblastic Leukemia 

Roaa Shoukry, The Hospital for Sick Children


Emotion and Symptom-focused Engagement (EASE): Qualitative Evaluation of a Psychosocial Intervention for Family Caregivers of Children with Acute Leukemia

Ally Yu, Princess Margaret Cancer Centre


POGO Satellite Clinic Program: A data-driven approach to monitoring and improving access to high quality care closer to home

Felicia Leung, POGO

Ally Yu picture
Ally Yu
Roaa Shoukry picture
Roaa Shoukry
Felicia Leung picture
Felicia Leung
4:10 PM — 5:00 PM
Addressing Health Disparities in Pediatric Oncology

Despite standardized care on multi-center clinical trials, children exposed to adverse social determinants of health are more likely to relapse and die, and their families suffer inferior psychosocial outcomes. This presentation will discuss opportunities to improve outcomes in pediatric cancer by systematically considering social determinants of health as risk factors for poor outcome and integrating them into the existing robust clinical trial and basic science models of discovery and care in pediatric cancer.

Kira Bona picture
Kira Bona
5:00 PM — 5:05 PM
Survivor Perspectives: Alexx's Story
8:00 AM — 8:30 AM
Breakfast/Posters on Display
8:30 AM — 8:35 AM
Survivor Perspectives: Noor's Story
8:35 AM — 8:50 AM
Rapid Fire Research: 3-minute poster presentations

 

TP53 Mutational Clusters Stratify the Li-Fraumeni Syndrome Spectrum and Reveal an Osteosarcoma-Prone Subgroup 

Nicholas Fischer, The Hospital for Sick Children


Innovative Backpacks for Kids and Teens Receiving Blinatumomab 

Alia Petropoulos, The Hospital for Sick Children


Bereaved Children's Questions About Illness, Death and Grief: What they Wonder, and How to Respond

Ashwini Pugazhendhi, McMaster University


Increased Probability of Relapse Associated with Thromboembolism and Bloodstream Infections during Primary Therapy for Acute Lymphblastic Leukemia in Children: Results of a Provincial Prospective Study

Louise Guolla, McMaster University

Ashwini Pugazhendhi picture
Ashwini Pugazhendhi
Nick Fischer picture
Nick Fischer
Louise Guolla picture
Louise Guolla
Alia Petropoulos picture
Alia Petropoulos
8:50 AM — 9:40 AM
Challenging Cases in Neuroblastoma

Through the use of case examples, this presentation will review some of the complexities in managing neuroblastoma including initial decision-making relating to risk stratification, new treatment approaches and the challenges in treating patients with relapsed high-risk disease.

Daniel Morgenstern picture
Daniel Morgenstern
9:40 AM — 10:00 AM
Morning Break

SPECIAL INTEREST SESSIONS

Special interest sessions take place concurrently. There are four to choose from and they are offered on both Friday and Saturday. These sessons are designed to be interactive and conducive to discussion and collective problem-solving. 

10:00 AM — 11:00 AM
Special Interest Session A: Interesting Cases in Pediatric Lymphoma

Using patient-based scenarios, this session will focus on the complexities and emerging opportunities in the management of Hodgkin lymphoma in childhood, adolescents, and young adults. In addition, participants are invited to engage in a discussion of the role of patient reported outcomes, shared decision making and drug access in treatment decisions.

Angela Punnett picture
Angela Punnett
Jennifer Seelisch picture
Jennifer Seelisch
10:00 AM — 11:00 AM
Special Interest Session B: Decision-making in Adolescents and Young Adults with Cancer
Abha Gupta picture
Abha Gupta
Kim Pyke-Grimm picture
Kim Pyke-Grimm
10:00 AM — 11:00 AM
Special Interest Session C: Diagnostic and Treatment Advances in Pediatric Solid Tumours

Despite survival improvements owed to traditional cytotoxic chemotherapy in pediatric solid tumors in the past 4 decades, patients with relapsed or refractory disease continue to have poor outcomes. There is a clear need therefore for novel therapeutics and targeted agents in this difficult to treat patient population. This session will use a series of solid tumor cases to explore the considerations in using novel therapeutics both within and outside of clinical trial settings.

Paul Gibson picture
Paul Gibson
Marija Kacar picture
Marija Kacar
10:00 AM — 11:00 AM
Special Interest Session D: Overcoming Barriers to Make Fertility Preservation Standard of Care in Ontario
Jennia Michaeli picture
Jennia Michaeli
Stacy Whiteside picture
Stacy Whiteside
11:05 AM — 12:20 PM
‘Two-cents’ from an expert panel – Where to spend the next available dollar to advance the field of pediatric oncology?

There have been tremendous clinical and scientific advances in the field of pediatric oncology over the last 40 years, but there is always more to do. Join us for a dynamic discussion featuring a range of expert opinions on setting priorities and harnessing available resources to continually improve care for pediatric cancer patients, survivors and their families.

David Malkin picture
David Malkin
Kira Bona picture
Kira Bona
Fiona Schulte picture
Fiona Schulte
Iain Macri picture
Iain Macri
Chantelle Bacon picture
Chantelle Bacon
12:20 PM — 12:40 PM
Lunch Opens for Lunch 'n Learn Session
12:40 PM — 1:25 PM
Lunch 'n Learn: Improving Diagnostic Accuracy of Childhood Cancers using Artificial Intelligence

This presentation will focus on a new RNA-based platform, developed in the Shlien lab at The Hospital for Sick Children, which has the potential to become a universal diagnostic test for childhood cancer.

Adam Shlien picture
Adam Shlien
1:25 PM — 1:30 PM
Poster Awards & Closing Remarks

Detected timezone